Citation: S. Faderl et Z. Estrov, RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD - METHODS OF DETECTION AND CLINICAL RELEVANCE, Cytokines cellular & molecular therapy, 4(2), 1998, pp. 73-85
Authors:
BERAN M
CAO XB
ESTROV Z
JEHA S
JIN GZ
OBRIEN S
TALPAZ M
ARLINGHAUS RB
LYDON NB
KANTARJIAN H
Citation: M. Beran et al., SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING M-R-190,000 BCR-ABLPROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148), Clinical cancer research, 4(7), 1998, pp. 1661-1672
Citation: Z. Estrov et al., RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD - DETECTION, QUANTITATION, CHARACTERIZATION AND CLINICAL-SIGNIFICANCE, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 251-266
Authors:
LIU JW
HADJOKAS N
MOSLEY B
ESTROV Z
SPENCE MJ
VESTAL RE
Citation: Jw. Liu et al., ONCOSTATIN M-SPECIFIC RECEPTOR EXPRESSION AND FUNCTION IN REGULATING CELL-PROLIFERATION OF NORMAL AND MALIGNANT MAMMARY EPITHELIAL-CELLS, Cytokine, 10(4), 1998, pp. 295-302
Authors:
WRIGHTBROWNE V
SCHNEE AM
JENKINS MA
THALL PF
AGGARWAL BB
TALPAZ M
ESTROV Z
Citation: V. Wrightbrowne et al., SERUM CYTOKINE LEVELS IN INFECTIOUS-MONONUCLEOSIS AT DIAGNOSIS AND CONVALESCENCE, Leukemia & lymphoma, 30(5-6), 1998, pp. 583-589
Citation: S. Faderl et Z. Estrov, THE CLINICAL-SIGNIFICANCE OF DETECTION OF RESIDUAL DISEASE IN CHILDHOOD ALL, Critical reviews in oncology/hematology, 28(1), 1998, pp. 31-55
Authors:
KURZROCK R
TALPAZ M
BERAN M
HARRIS D
ESTROV Z
Citation: R. Kurzrock et al., DNA IN-SITU HYBRIDIZATION OF INDIVIDUAL COLONIES TO DETERMINE LINEAGEDERIVATION IN LEUKEMIA, Leukemia, 12(2), 1998, pp. 242-246
Authors:
KURZROCK R
ESTROV Z
KANTARJIAN H
TALPAZ M
Citation: R. Kurzrock et al., CONVERSION OF INTERFERON-INDUCED, LONG-TERM CYTOGENETIC REMISSIONS INCHRONIC MYELOGENOUS LEUKEMIA TO POLYMERASE-CHAIN-REACTION NEGATIVITY, Journal of clinical oncology, 16(4), 1998, pp. 1526-1531
Authors:
DHINGRA K
SAHIN A
EMAMI K
HORTOBAGYI GN
ESTROV Z
Citation: K. Dhingra et al., EXPRESSION OF LEUKEMIA INHIBITORY FACTOR AND ITS RECEPTOR IN BREAST-CANCER - A POTENTIAL AUTOCRINE AND PARACRINE GROWTH-REGULATORY MECHANISM, Breast cancer research and treatment, 48(2), 1998, pp. 165-174
Authors:
ESTROV Z
TALPAZ M
KU S
HARRIS D
VAN Q
BERAN M
HIRSCHGINSBERG C
HUH Y
YEE G
KURZROCK R
Citation: Z. Estrov et al., Z-138 - A NEW MATURE B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE FROM A PATIENT WITH TRANSFORMED CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia research, 22(4), 1998, pp. 341-353
Authors:
KURZROCK R
ESTROV Z
KU S
LEONARD M
TALPAZ M
Citation: R. Kurzrock et al., INTERLEUKIN-1 INCREASES EXPRESSION OF THE LYT-10 (NF-KAPPA-B2) PROTOONCOGENE TRANSCRIPTION FACTOR IN RENAL-CELL CARCINOMA LINES, The Journal of laboratory and clinical medicine, 131(3), 1998, pp. 261-268
Authors:
KONOPLEVA M
ESTROV Z
ZHAO SR
ANDREEFF M
MEHTA K
Citation: M. Konopleva et al., LIGATION OF CELL-SURFACE CD38 PROTEIN WITH AGONISTIC MONOCLONAL-ANTIBODY INDUCES A CELL-GROWTH SIGNAL IN MYELOID-LEUKEMIA CELLS, The Journal of immunology (1950), 161(9), 1998, pp. 4702-4708
Authors:
ARLINGHAUS RB
LIU J
WU Y
MA G
LIN SH
ESTROV Z
TALPAZ M
Citation: Rb. Arlinghaus et al., BCR IS A CONDITIONAL NEGATIVE REGULATOR OF BCR-ABL INDUCED LEUKEMIAS, British Journal of Haematology, 102(1), 1998, pp. 155-155
Authors:
ESTROV Z
THALL PF
TALPAZ M
ESTEY EH
KANTARJIAN HM
ANDREEFF M
HARRIS D
VAN Q
WALTERSCHEID M
KORNBLAU SM
Citation: Z. Estrov et al., CASPASE-2 AND CASPASE-3 PROTEIN-LEVELS AS PREDICTORS OF SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA, Blood, 92(9), 1998, pp. 3090-3097
Citation: S. Faderl et al., CLINICAL-SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 91(11), 1998, pp. 3995-4019
Authors:
MCCLAIN KM
ESTROV Z
RAJU U
KELLEY PK
AGGARWAL BB
Citation: Km. Mcclain et al., EPSTEIN-BARR-VIRUS EBNA-2 GENE-EXPRESSION ENHANCES LYMPHOTOXIN PRODUCTION BY B-LYMPHOCYTES, Methods, 11(1), 1997, pp. 83-87
Citation: Z. Estrov et M. Talpaz, ROLE OF INTERLEUKIN-1-BETA CONVERTING-ENZYME (ICE) IN ACUTE MYELOGENOUS LEUKEMIA-CELL PROLIFERATION AND PROGRAMMED CELL-DEATH, Leukemia & lymphoma, 24(5-6), 1997, pp. 379-391
Authors:
WETZLER M
KURZROCK R
ESTROV Z
BARONE S
ESTEY E
TALPAZ M
Citation: M. Wetzler et al., SUPPRESSED FORMATION OF BONE-MARROW ADHERENT LAYERS DERIVED FROM ACUTE MYELOID-LEUKEMIA PATIENTS AFTER IN-VITRO EXPOSURE TO INTERLEUKIN-4, Leukemia research, 21(6), 1997, pp. 519-527
Authors:
ROBERTS WM
ESTROV Z
OUSPENSKAIA MV
JOHNSTON DA
MCCLAIN KL
ZIPF TF
Citation: Wm. Roberts et al., MEASUREMENT OF RESIDUAL LEUKEMIA DURING REMISSION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, The New England journal of medicine, 336(5), 1997, pp. 317-323
Authors:
PELEG S
QIU HY
REDDY S
HARRIS D
VAN Q
ESTEY EH
TALPAZ M
ESTROV Z
Citation: S. Peleg et al., 1,25-DIHYDROXYVITAMIN D-3 AND ITS ANALOGS INHIBIT ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION BY SUPPRESSING INTERLEUKIN-1-BETA PRODUCTION, The Journal of clinical investigation, 100(7), 1997, pp. 1716-1724
Authors:
KORNBLAU SM
THALL P
WALTERSCHEID M
ESTROV Z
KEATING M
PATEL S
KANTARJIAN H
ESTEY E
ANDREEFF M
Citation: Sm. Kornblau et al., ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS WITH LOWER LEVELS OF BCL2 EXPRESSION AND UNFAVORABLE CYTOGENETICS HAVE A VERY POOR-PROGNOSIS, Blood, 90(10), 1997, pp. 3707-3707
Authors:
KANTARJIAN H
MANSHOURI PT
ESTROV Z
TALPAZ M
OBRIEN S
BERAN M
PIERCE S
ESTEY E
KEATING M
ALBITAR M
Citation: H. Kantarjian et al., SIGNIFICANCE OF C-MPL EXPRESSION IN PHILADELPHIA-CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 4000-4000
Authors:
ALBITAR M
MANSHOURI T
KANTARJIAN H
KEATING M
ESTROV Z
FABER J
FREIREICH E
PIERCE S
ESTEY E
Citation: M. Albitar et al., FAVORABLE CYTOGENETIC GROUPS IN ACUTE MYELOID-LEUKEMIA (AML) DO NOT OVEREXPRESS C-MPL PROTEIN, Blood, 90(10), 1997, pp. 273-273